Emergent BioSolutions doses first patient in Phase 1 Anthrax trial
Views 342
Tweet
Source:
www.pharmaceutical-business-review.com
Close Source
1
Apothecary to distribute Pfizer Inlyta drug
1
GSK launches Medivir cold sore OTC product in Europe
1
Teva UK introduces generic Glaucoma drops
